Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RO4995819 adjunctive therapy in major depressive disorder with inadequate antidepressant response
2011-002160-24Phase 2Completed
- Sponsor
- Roche
- Start
- Dec 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in major depressive disorder (MDD) comparing RO4995819 adjunctive therapy with Placebo adjunctive therapy (2 arms). Primary endpoint: Primary efficacy endpoint. Started Dec 2011; status: completed.
02
Drugs
Decoglurant
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on 2011-002160-24.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-002160-24.